Healthcare-Associated Infections in Patients with COVID-19: Is It Different from the Pre-Pandemic Period
No Thumbnail Available
Date
2024
Journal Title
Journal ISSN
Volume Title
Publisher
Journal of Infection in Developing Countries
Open Access Color
OpenAIRE Downloads
OpenAIRE Views
Abstract
Introduction: Healthcare-associated infections (HAIs) are common in intensive care unit (ICU) patients and may cause devastating consequences. However, the prevalence of HAI and its effects on in-hospital mortality among critically ill COVID-19 patients is ambiguous. We determined the prevalence of HAI and the rate of mortality in critically ill COVID-19 patients and compared it with pre-pandemic ICU patients. Methodology: This retrospective study was conducted with adult ICU patients admitted to Gazi Yasargil Training and Research Hospital (Diyarbakir,Turkey) in April-November 2019 (defined as the pre-pandemic period) and in April-November 2020 (defined as the pandemic period). All patients in the pandemic period had COVID-19, while none in the pre-pandemic period did. Patients diagnosed with HAIs during the in-hospital follow-up period were recorded. Results: Of 4596 enrollees, 3386 (73.7%) were pandemic-period patients and 1210 (26.3%) were pre-pandemic-period patients. HAI prevalence was significantly higher at 5.9% (n = 71) in the pandemic-period patients and 2.7% (n = 91) in the pre-pandemic-period patients (p < 0.001). Comorbidities including hypertension (63.4% vs 14.2%, p < 0.001), diabetes mellitus (39.4% vs 8.8%, p < 0.001), and coronary artery disease (30.9% vs 10.9%, p = 0.002) were significantly more frequent in pandemic-period HAI-positive patients. The most common HAI was catheter-related bloodstream infection in both groups, with similar frequency (p = 0.652). In-hospital mortality rate was 85.9% versus 65.9% in pandemic- versus pre-pandemic-period HAI-positive patients (p < 0,05). Conclusions: The prevalence of HAI and the in-hospital mortality rate was significantly higher among pandemic-period patients. © 2024 Elsevier B.V., All rights reserved.
Description
Keywords
COVID-19, Healthcare-Associated Infections, Intensive Care Units, C Reactive Protein, Lactate Dehydrogenase, Lactate Dehydrogenase A, Procalcitonin, SPSS 24, C Reactive Protein, Lactate Dehydrogenase, Procalcitonin, Acinetobacter baumannii, Adult, Aged, Article, Bloodstream Infection, Chronic Kidney Failure, Chronic Obstructive Lung Disease, Coronary Artery Disease, Coronavirus Disease 2019, Critically Ill Patient, Diabetes Mellitus, Escherichia coli, Female, Healthcare Associated Infection, Hospitalization, Human, Hypertension, Intensive Care Unit, Klebsiella pneumoniae, Length of Stay, Major Clinical Study, Male, Middle Aged, Morganella morganii, Mortality, Pandemic, Polymerase Chain Reaction, Prevalence, Retrospective Study, Staphylococcus aureus, Urinalysis, Urinary Tract Infection, Ventilator Associated Pneumonia, Comorbidity, Complication, Critical Illness, Cross Infection, Epidemiology, Hospital Mortality, Severe Acute Respiratory Syndrome Coronavirus 2, Turkey (Bird), Adult, Aged, Comorbidity, COVID-19, Critical Illness, Cross Infection, Female, Hospital Mortality, Humans, Intensive Care Units, Male, Middle Aged, Prevalence, Retrospective Studies, SARS-CoV-2, Turkey
Turkish CoHE Thesis Center URL
Fields of Science
Citation
WoS Q
Q4
Scopus Q
Q3
Source
Journal of Infection in Developing Countries
Volume
18
Issue
9
Start Page
S67
End Page
S72
Google Scholar™
Sustainable Development Goals
16
PEACE, JUSTICE AND STRONG INSTITUTIONS
